$DK

Delek US Q2 Earnings Call Highlights

Delek US (NYSE: DK) Q2 earnings call covered refining margins, throughput guidance, and cash flow. Management said refined-product markets may take several quarters to normalize and that a less backwardated forward curve could lift realized crack spreads. Q3 throughput guided to 296,000-316,000 bpd, with Opex $220-$230M and D&A $110-$120M. Delek Logistics Partners reported ~$144M adjusted EBITDA and reaffirmed 2026 guidance of $520-$560M.

Original reporting
Published Aug 9, 2026, 9:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 9, 2026, 9:16 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Delek US Q2 Earnings Call Highlights — source image
Decision brief

The 30-second read

$DKBullishMed
01

Why it matters

For DK, the most tradable elements are the explicit Q3 throughput and expense ranges, the quantified EOP contribution to Q2 profit, the reaffirmed 2026 Delek Logistics EBITDA guidance, and management’s stance on RVO cost burden and expected EPA relief. Together these can shift near-term earnings estimates and cash-flow expectations, while also framing regulatory risk around RIN-related proceeds.

02

Market read

DK’s Q3 operational and cost guidance, plus EOP and logistics EBITDA updates, provide a concrete re-rating framework for near-term cash-flow and earnings expectations.

03

What to watch

The article notes a large net working-capital outflow in Q2; traders may need to assess whether that pattern persists and how it affects free cash flow versus accounting earnings.

Relevance 7/10Novelty 7/10Timing: pre-market today, following the Q2 earnings call

Background

The piece summarizes Delek US’s Q2 earnings call Q&A, focusing on refining margins, throughput and expense guidance, optimization initiatives, logistics performance, and Renewable Fuel Standard small refinery exemption commentary.

Company-level read

Ticker impact

$DKBullishMedium confidence
Context

Delek US guided Q3 throughput to 296,000 to 316,000 bpd and forecast operating expenses, D&A, and EOP contribution to profit.

Expected impact

Likely supportive for DK if investors view throughput and margin-capture assumptions as achievable, with upside bias from EOP cash-flow run-rate and logistics EBITDA strength.

Evidence & confidence

The article includes specific Q3 throughput and expense ranges, a quantified EOP profit contribution, and reaffirmed 2026 logistics EBITDA guidance, all of which can re-anchor DK’s near-term earnings model and cash-flow expectations. However, it is still an earnings-call highlight rather than a full financial statement, and margin/backwardation assumptions are market-dependent.

Market effects

Refining margins and RIN/RVO cost relief expectations are reiterated, which can influence sentiment toward downstream refiners with small refinery exemption exposure.

Emphasis on Gulf Coast and Midcontinent access may reinforce confidence in inland refiners’ feedstock optionality.

Limited direct global linkage beyond general refined-product market normalization timing.

Counterpoint

Guidance is range-based and depends on normalization of refined-product markets and backwardation dynamics, which could reverse if outages end sooner or cracks compress.

Key entities

  • Delek US Holdings, Inc

    Independent downstream refiner and logistics operator; subject of the earnings-call highlights and guidance.

  • Delek Logistics Partners

    Logistics partnership discussed for adjusted EBITDA performance and 2026 guidance.

  • U.S. EPA

    Referenced regarding continued relief for small refinery exemptions under the Renewable Fuel Standard.

Related articles

$DKMedAI 8/10

Delek US Holdings (DK) Q2 2026 Earnings Call Transcript

Delek US Holdings (DK) reported Q2 2026 net income of $170 million ($2.71/share) and adjusted net income of $344 million ($5.48/share). Adjusted EBITDA was $639 million, with RVO-adjusted EBITDA of $490 million and RVO-adjusted EPS of $3.64. Logistics segment adjusted EBITDA was a record $144 million. DKL full-year 2026 EBITDA guidance is $520 million to $560 million.

$DKMed

Delek Slides on Q2 Results

Delek US Holdings (NYSE: DK) reported Q2 ended June 30, 2026 net income of $169.5M ($2.71/share) and adjusted net income of $343.9M ($5.48/share). Adjusted EBITDA was $638.7M; excluding RVO impacts, adjusted EPS was $3.64 and adjusted EBITDA $490.1M. Delek Logistics posted adjusted EBITDA of $143.5M and is targeting $520-560M. Delek bought $20M of DK shares and paid $15.6M in dividends, declaring a $0.255 quarterly dividend.

$DKMedAI 8/10

This is Why Delek US Holdings, Inc. (DK) is One of the Best Oil Stocks to Buy Amid US-Iran War

Delek US Holdings (NYSE:DK) said on April 29 it is improving cash flow via its Enterprise Optimization Plan. In Q1, it completed the Big Spring refinery turnaround on time and on budget and continued ramp-up of the Delaware basin Libby 2 sour gas plant. Adjusted net income was $4.7M ($0.08/share) and adjusted EBITDA $211.7M. Revenue was $2.65B vs $2.42B expected; it ended with $624.1M cash and $3.18B long-term debt.

$TPBMedAI 8/10

Turning Point Brands Q2 Earnings Call Highlights

Turning Point Brands (NYSE:TPB) reported Q2 segment updates and raised 2026 Modern Oral outlook. Adjusted gross sales guidance for Modern Oral increased to $330M-$350M and net sales to $260M-$270M. It kept full-year adjusted EBITDA at $70M-$90M. The company said it ended Q2 with $268M cash and $26M free cash flow, helped by an $18M tariff refund.

$FIGSHighAI 9/10

FIGS Q2 Earnings Call Highlights

FIGS (NYSE:FIGS) reported Q2 results and an earnings call update. International revenue rose 67% to $37.9M and U.S. revenue grew 22% to $158.7M. Gross margin increased to 75.2% with a $15.4M tariff refund benefit. Net income was $28.4M, or $0.15/share. FIGS raised FY2026 revenue growth to ~20% and operating margin to ~10.8%, and repurchased about $24M of shares.

$ELFMedAI 8/10

Rhode Is Fueling e.l.f.'s Latest Surge. Is It Time to Jump In?

e.l.f. Beauty (ELF) shares rose after the company reported fiscal Q1 results and raised full-year guidance. Sales grew 36% to $479.4M and adjusted EPS rose to $1.75 (traffic refund noted). Rhode contributed $160M sales. Full-year revenue guidance increased to $1.938B-$1.968B and adjusted EPS to $3.50-$3.55.